Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/mitogen-activated protein kinase signal transduction cascade

Journal of Neuroscience

Volumn 19, Issue 19, 1999, Pages 8685-8695

  Pierce, R Christopher ^a   Pierce Bancroft, Audrey F ^a   Prasad, Balakrishna M ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Behavioral sensitization; Brain derived neurotrophic factor (BDNF); Cocaine; Mitogen activated protein (MAP) kinase; Neurotrophin 3 (NT 3); Neurotrophins; Substantia nigra; Ventral tegmental area (VTA)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN 3;

ANIMAL BEHAVIOR; ARTICLE; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; MICROINJECTION; NERVE CELL PLASTICITY; NERVE STIMULATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 0033216135     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-19-08685.1999     Document Type: Article

References (72)

1. Ackerman JM, White FJ (1990) A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci Lett 117:181-187.
2. Akimoto K, Hamamura T, Otsuki S (1989) Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studies by in vivo intracerebral dialysis. Brain Res 490:339-344.
3. Beck KD, Knusel B, Winslow JW, Rosenthal A, Burton K, Nikolics K, Hefti F (1992) Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenylpyridinium. Neurodegeneration 1:27-36.
4. Beitner-Johnson D, Nestler EJ (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57:344-347.
5. Benisty S, Boissiere F, Faucheux B, Agid Y, Hirsch EC (1998) trkB messenger mRNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study. Neuroscience 86:813-826.
6. Berhow MT, Russell DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM, Nestler EJ (1995) Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68:969-979.
7. Berhow MT, Hiroi N, Nestler EJ (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4707-4715.
8. Bjijou Y, Stinus L, Le Moal M, Cador M (1996) Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J Pharmacol Exp Ther 277:1177-1187.
9. Bothwell M (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18:223-253.
10. Cathala G, Savouret JF, Mendez B, West BL, Karin M, Martial JA, Baxter JD (1983) A method for isolation of intact, translationally active ribonucleic acid. DNA 2:329-335.
11. Ceccatelli S, Ernfors P, Villar MJ, Persson H, Hokfelt T (1991) Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci USA 88:10352-10356.
12. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-2313.
13. Davies AM (1994) The role of neurotrophins in the developing nervous system. J Neurobiol 25:1334-1348.
14. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689.
15. Egea J, Espinet C, Comella JX (1999) Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells. J Biol Chem 274:75-85.
16. Ernfors P, Wetmore C, Olson L, Persson H (1990) Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5:511-526.
17. Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME, Feig LA (1995) Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 376:524-527.
18. Gall CM, Gold SJ, Isackson PJ, Seroogy KB (1992) Brain-derived neurotrophic factor and neurotrophin 3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 3:56-63.
19. Hagg T (1998) Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo, Exp Neurol 149:183-192.
20. Haycock JW, Ahn NG, Cobb MH, Krebs EG (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc Natl Acad Sci USA 89:2365-2369.
21. Henry DJ, Greene MA, White FJ (1989) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther 251:833-839.
22. Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR (1999) Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19:4110-4122.
23. Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
24. Kalivas PW, Alesdatter JE (1993) Involvement of NMDA receptor stimulation in the VTA and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495.
25. Kalivas PW, Duffy P (1993a) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275.
26. Kalivas PW, Duffy P (1993b) Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J Neurosci 13:276-284.
27. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
28. Kalivas PW, Hooks MS, Sorg B (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334.
29. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45:599-606.
30. Knusel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 88:961-965.
31. Kolta MG, Shreve P, De Souza V, Uretsky NJ (1985) Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24:823-829.
32. Lauterborn JC, Isackson PJ, Gall CM (1991) Nerve growth factor messenger RNA-containing cells are distributed within regions of cholinergic neurons in the rat basal forebrain. J Comp Neurol 306:439-446.
33. Lauterborn JC, Bizon JL, Tran TM, Gall CM (1995) NGF mRNA is expressed by GABAergic but not cholinergic neurons in the rat basal forebrain. J Comp Neurol 360:454-462.
34. Lee TH, Ellinwood Jr EH, Nishita JK (1988) Dopamine receptor sensitivity changes with chronic stimulants. Ann NY Acad Sci 537:324-329.
35. Lewin GR, Barde Y-A (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
36. Martin-Iverson MT, Altar CA (1996) Spontaneous behaviors of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3. Eur J Neurosci 8:1696-1706.
37. Martin-Iverson MT, Todd KG, Altar CA (1994) Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 14:1262-1270.
38. 2-receptor mechanisms. Neurosci Lett 217:73-76.
39. McAllister AK, Katz LC, Lo DC (1996) Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 17:1057-1064.
40. Numan S, Seroogy KB (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J Comp Neurol 403:295-308.
41. Orban PC, Chapman PF, Brambilla R (1999) Is the Ras-MAPK signalling pathway necessary for long-term memory formation? Trends Neurosci 22:38-44.
42. Parsons LH, Justice Jr JB (1993) Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area and dorsal raphe nucleus following repeated cocaine administration. J Neurochem 61:1611-1619.
43. Paulson PE, Robinson TE (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19:56-65.
44. Paxinos G, Watson C (1997) The rat brain in stereotoxic coordinates. San Diego: Academic.
45. Perugini M, Vezina P (1994) Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690-696.
46. Pierce RC, Kalivas PW (1996) Amphetamine produces sensitized locomotion and dopamine release preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther 275:1019-1029.
47. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitizalion to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
48. Pierce RC, Kalivas PW (1998) Locomotor behavior. In: Current protocols in neuroscience (Crawley J, ed). New York: Wiley.
49. Pierce RC, Born B, Adams M, Kalivas PW (1996) Repeated intraventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. J Pharmacol Exp Ther 278:384-392.
50. Pierce RC, Quick EA, Reeder DC, Morgan ZR, Kalivas PW (1998) Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 286:1171-1176.
51. Robinson TE, Berridge KC (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
52. Robinson TE, Kolb B (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17:8491-8497.
53. Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by previous experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211-222.
54. Schuman E (1999) Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 9:105-109.
55. Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726-735.
56. Seroogy KB, Lundgren KH, Tran TMD, Guthrie KM, Isackson PJ, Gall CM (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 342:321-334.
57. Shimada A, Mason CA, Morrison ME (1998) TrkB signaling modulates spine density and morphology independent of dendrite structure in cultured neonatal Purkinje cells. J Neurosci 18:8559-8570.
58. Sorg BA, Chen S-Y, Kalivas PW (1993) Time course of tyrosine hydroxylase expression following behavioral sensitization to cocaine. J Pharmacol Exp Ther 266:424-430.
59. Spillantini MG, Aloe L, Alleva E, de Simone R, Goedert M, Levi-Montalcini R (1989) Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. Proc Natl Acad Sci USA 86:8555-8559.
60. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99-106.
61. Stewart J, Druhan JP (1993) The development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the noncompetitive NMDA receptor antagonist, MK-801. Psychopharmacology 110:125-132.
62. 2+ ionophore-induced apoptosis of cultured cortical neurons: involvement of dual pathways. Neuropharmacology 38:283-288.
63. Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270:593-598.
64. Timmusk T, Belluardo N, Metsis M, Persson H (1993) Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur J Neurosci 5:605-613.
65. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 16:2411-2420.
66. Vincent SR, Sebben M, Dumuis A, Bockaert J (1998) Neurotransmitter regulation of MAP kinase signalling in striatal neurons in primary culture. Synapse 29:29-36.
67. Vrana SL, Vrana KE, Koves TR, Smith JE, Dworkin SI (1993) Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem 61:2262-2268.
68. White FJ, Xiu Y-H, Henry DJ, Zhang X-F (1995) Neurophysiological alterations in the mesocorticolimbic dopamine system during repeated cocaine administration. In: The neurobiology of cocaine addiction (Hammer R, ed), pp 99-120. Boca Raton, FL: CRC.
69. Wolf ME, Khansa MR (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
70. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR (1993) Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 264:249-255.
71. Xia Z, Dudek H, Miranti CK, Greenberg ME (1996) Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J Neurosci 16:5425-5436.
72. Zhang Y, Angulo JA (1996) Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain. Synapse 24:218-223.